<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genet Res (Camb)</journal-id>
<journal-id journal-id-type="iso-abbrev">Genet Res (Camb)</journal-id>
<journal-id journal-id-type="publisher-id">GRH</journal-id>
<journal-title-group>
<journal-title>Genetics Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-6723</issn>
<issn pub-type="epub">1469-5073</issn>
<publisher>
<publisher-name>Cambridge University Press</publisher-name>
<publisher-loc>Cambridge, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27350105</article-id>
<article-id pub-id-type="pmc">6865162</article-id>
<article-id pub-id-type="doi">10.1017/S0016672316000082</article-id>
<article-id pub-id-type="pii">S0016672316000082</article-id>
<article-id pub-id-type="publisher-id">00008</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>FMR1</italic> gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile</article-title>
<alt-title alt-title-type="left-running">L. Santa María <italic>et al.</italic></alt-title>
<alt-title alt-title-type="right-running"><italic>FMR1</italic> mutations: 30 years of experience in Chile</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>SANTA MARÍA</surname>
<given-names>LORENA</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<xref ref-type="author-notes" rid="fns01">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>ALIAGA</surname>
<given-names>SOLANGE</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="author-notes" rid="fns01">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>FAUNDES</surname>
<given-names>VÍCTOR</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>MORALES</surname>
<given-names>PAULINA</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>PUGIN</surname>
<given-names>ÁNGELA</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>CUROTTO</surname>
<given-names>BIANCA</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>SOTO</surname>
<given-names>PAULA</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>PEÑA</surname>
<given-names>M. IGNACIA</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>SALAS</surname>
<given-names>ISABEL</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>ALLIENDE</surname>
<given-names>M. ANGÉLICA</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Cytogenetics and Molecular Laboratory</addr-line>, <addr-line>Institute of Nutrition and Food Technology (INTA)</addr-line>, <institution>University of Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff>
<aff id="aff2"><label>2</label><addr-line>Center for Diagnosis and Treatment of Fragile X Syndrome Patients (CDTSXF)</addr-line>, <addr-line>Institute of Nutrition and Food Technology (INTA)</addr-line>, <institution>University of Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff>
<aff id="aff3"><label>3</label><addr-line>Cyto-Molecular Diagnostic Research Laboratory</addr-line>, <institution>Victorian Clinical Genetics Services and Murdoch Childrens Research Institute</institution>, <addr-line>Royal Children's Hospital</addr-line>, <addr-line>Melbourne Victoria</addr-line>, <country>Australia</country></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Paediatrics</addr-line>, <institution>University of Melbourne</institution>, <addr-line>Melbourne Victoria</addr-line>, <country>Australia</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding author: <addr-line>Lorena Santa María</addr-line>, <addr-line>Molecular Cytogenetics Laboratory</addr-line>, <addr-line>INTA</addr-line>, <institution>University of Chile</institution>, <addr-line>El Líbano 5524</addr-line>, <addr-line>PO 7830490</addr-line>, <addr-line>Santiago</addr-line>, <country>Chile</country>. Tel: <phone>56-2-29781494</phone>. Fax: <fax>56-2-29781489</fax>. E-mail: <email>lsantamaria@inta.uchile.cl</email></corresp>
<fn id="fns01">
<label>†</label>
<p>Both authors share the responsibility of the first author</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>6</month>
<year>2016</year>
</pub-date>
<volume>98</volume>
<elocation-id>e11</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>1</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© Cambridge University Press 2016</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Cambridge University Press</copyright-holder>
</permissions>
<self-uri xlink:href="S0016672316000082a.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="normal">
<title>Summary</title>
<p>Fragile X syndrome (FXS) is the most common form of inherited intellectual disability (ID) and co-morbid autism. It is caused by an amplification of the CGG repeat (&gt;200), which is known as the full mutation, within the 5′UTR of the <italic>FMR1</italic> gene. Expansions between 55–200 CGG repeats are termed premutation and are associated with a greater risk for fragile X-associated tremor/ataxia syndrome and fragile X-associated premature ovarian insufficiency. Intermediate alleles, also called the grey zone, include approximately 45–54 repeats and are considered borderline. Individuals with less than 45 repeats have a normal <italic>FMR1</italic> gene. We report the occurrence of CGG expansions of the <italic>FMR1</italic> gene in Chile among patients with ID and families with a known history of FXS. Here, we present a retrospective review conducted on 2321 cases (2202 probands and 119 relatives) referred for FXS diagnosis and cascade screening at the Institute of Nutrition and Food Technology (INTA), University of Chile. Samples were analysed using traditional cytogenetic methods and/or PCR. Southern blot was used to confirm the diagnosis. Overall frequency of <italic>FMR1</italic> expansions observed among probands was 194 (8·8%), the average age of diagnosis was 8·8 ± 5·4 years. Of 119 family members studied, 72 (60%) were diagnosed with a CGG expansion. Our results indicated that the prevalence of CGG expansions of the <italic>FMR1</italic> gene among probands is relatively higher than other populations. The average age of diagnosis is also higher than reference values. PCR and Southern blot represent a reliable molecular technique in the diagnosis of FXS.</p>
</abstract>
<counts>
<table-count count="3"></table-count>
<ref-count count="56"></ref-count>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>